These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2220965)

  • 1. Clinical acceptability of monophasic gestodene.
    Düsterberg B; Brill K
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1398-404. PubMed ID: 2220965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open prospective multicenter trial with a new monophasic contraceptive combination containing gestodene.
    Renier M; Buytaert P
    Contraception; 1991 May; 43(5):413-21. PubMed ID: 1914456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with a low-dose oral contraceptive containing gestodene.
    Düsterberg B; Brill K
    Adv Contracept; 1990 Dec; 6 Suppl():37-49; discussion 50. PubMed ID: 2291446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene.
    Fuchs N; Düsterberg B; Weber-Diehl F; Mühe B
    Contraception; 1995 Jun; 51(6):335-9. PubMed ID: 7554972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experiences with a gestodene containing oral contraceptive (femoden)].
    Gimes G; Valent S
    Acta Pharm Hung; 1998 Sep; 68(5):289-93. PubMed ID: 9805815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol. Latin American Oral Contraceptive Study Group.
    Contraception; 1994 Sep; 50(3):201-14. PubMed ID: 7805371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter clinical evaluation of a new monophasic combination: Minulet (gestodene and ethinyl estradiol).
    de Andrade RP
    Int J Fertil; 1989 Sep; 34 Suppl():22-30. PubMed ID: 2576253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of a low-dose contraceptive--Femodene].
    Rachev E; Damianov L; Dukovski A; Katsarova M
    Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experiences with femovan (Gynera)].
    Brill K; Düsterberg B; Albring M
    Ther Umsch; 1990 Dec; 47(12):958-65. PubMed ID: 2096480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical overview of a new triphasic contraceptive containing gestodene.
    Christie T
    Int J Fertil; 1989 Sep; 34 Suppl():40-9. PubMed ID: 2576257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
    Bilotta P; Favilli S
    Arzneimittelforschung; 1988 Jul; 38(7):932-4. PubMed ID: 2974702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
    Skouby SO
    Int J Fertil; 1987; 32 Suppl():45-8. PubMed ID: 2906346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triphasic combination of ethinyl estradiol and gestodene. Long-term clinical trial.
    Weber-Diehl F; Unger R; Lachnit U
    Contraception; 1992 Jul; 46(1):19-27. PubMed ID: 1424620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
    Chez RA
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1296-300. PubMed ID: 2524163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR; Sidelmann J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene.
    Düsterberg B; Ellman H; Müller U; Rowe E; Mühe B
    Gynecol Endocrinol; 1996 Feb; 10(1):33-9. PubMed ID: 8737190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.
    Wilde MI; Balfour JA
    Drugs; 1995 Aug; 50(2):364-95. PubMed ID: 8521763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.